Related Experiment Video

Updated: May 20, 2026

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
08:55

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on: April 17, 2019

Nuclear medicine in NET

Manfred Sorschag1, Phillip Malle, Hans-Jürgen Gallowitsch

  • 1Department of Nuclear Medicine and Endocrinology, PET-CT Center Klagenfurt, Feschnigstraße 11, 9020 Klagenfurt, Austria. manfred.sorschag@kabeg.at

Wiener Medizinische Wochenschrift (1946)
|July 20, 2012
PubMed

Insights

Nuclear imaging, particularly somatostatin receptor scintigraphy (SRS), is crucial for diagnosing neuroendocrine tumors (NET) and selecting patients for peptide receptor radionuclide therapy (PRRT). Advanced techniques like somatostatin receptor PET offer improved visualization of these rare tumors.

Area of Science:

  • Nuclear Medicine
  • Oncology
  • Radiology

Background:

  • Neuroendocrine tumors (NET) are rare, slow-growing neoplasms with endocrine and neural characteristics.
  • Conventional imaging has limitations in visualizing molecular biomarkers like somatostatin receptors (sstr).
  • Somatostatin receptor scintigraphy (SRS) is the gold standard for NET functional imaging due to high diagnostic accuracy.

Purpose of the Study:

  • To highlight the role of nuclear imaging in diagnosing NET.
  • To emphasize the importance of somatostatin receptor imaging for patient selection in peptide receptor radionuclide therapy (PRRT).
  • To discuss advancements in NET imaging, including PET-based techniques.

Main Methods:

  • Utilizing nuclear imaging techniques, specifically somatostatin receptor scintigraphy (SRS).
  • Evaluating somatostatin receptor PET and PET/CT with Ga-68-labeled analogs as advancements over SRS.
  • Considering FDG-PET and (18)F-DOPA PET as alternative or complementary imaging modalities for NET.

Main Results:

  • SRS accurately visualizes somatostatin receptor overexpression, a key biomarker in NET.
  • Ga-68-labeled somatostatin receptor analogs in PET/CT represent a significant development in SRS.
  • FDG-PET is limited to highly proliferative NET, while (18)F-DOPA is under assessment.

Conclusions:

  • Nuclear imaging, especially SRS and its PET-based evolution, is essential for NET diagnosis and PRRT patient selection.
  • Somatostatin receptor imaging remains the cornerstone for functional assessment of NET.
  • (18)F-DOPA shows promise as an alternative PET tracer for NET imaging.

More Related Videos

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules09:55

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Published on: October 4, 2024

Neutron Radiography and Computed Tomography of Biological Systems at the Oak Ridge National Laboratory's High Flux Isotope Reactor10:24

Neutron Radiography and Computed Tomography of Biological Systems at the Oak Ridge National Laboratory's High Flux Isotope Reactor

Published on: May 7, 2021

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Nuclear Transmutation03:20

Nuclear Transmutation

Nuclear transmutation is the conversion of one nuclide into another. It can occur by the radioactive decay of a nucleus, or the reaction of a nucleus with another particle. The first manmade nucleus was produced in Ernest Rutherford’s laboratory in 1919 by a transmutation reaction, the bombardment of one type of nuclei with other nuclei or with neutrons. Rutherford bombarded nitrogen-14 atoms with high-speed α particles from a natural radioactive isotope of radium and observed protons being...
Nuclear Magnetic Resonance (NMR): Overview01:07

Nuclear Magnetic Resonance (NMR): Overview

Nuclear magnetic resonance (NMR) is a phenomenon exhibited by certain nuclei that can absorb characteristic radio frequency radiation under certain conditions. NMR has been extensively applied in molecular spectroscopy and medical diagnostic imaging. In both these applications, the molecule or subject under study is placed in a magnetic field and irradiated with radio frequency energy.
NMR spectroscopy generates a spectrum where the characteristic absorption frequencies of the sample are...
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Isotopes and Radioisotopes01:28

Isotopes and Radioisotopes

In the early 1900s, English chemist Frederick Soddy realized that an element could have atoms with different masses that were chemically indistinguishable. These different types are called isotopes — atoms of the same element that differ in mass. Isotopes differ in mass because they have different numbers of neutrons but are chemically identical because they have the same number of protons. Soddy was awarded the Nobel Prize in Chemistry in 1921 for this discovery.
An isotope containing more...